Journal of Allergy and Clinical Immunology-In Practice

Article	Citations
Table of Contents	161
SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?	136
Practice Notes from the AAAI	125
The impact of COVID-19 on a national sample of US adults with food allergy	120
Reply to “How important is the second dose of the COVID-19 mRNA vaccine?”	111
Usability of Graphical User Interfaces With Semiautomatic Delabeling Feature to Improve Drug Allergy Documentation	107
European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives	106
Impact of an Inpatient Allergy Guideline on β-Lactam and Alternative Antibiotic Use	102
Information for Readers	100
March 2023 Practice Notes	85
Managing Atopic Dermatitis in Patients With Skin of Color	84
CME exam: Practical Implementation of Genetics: New Concepts in Immunogenomics to Predict, Prevent, and Diagnose Drug Hypersensitivity	83
Gene Therapy for Inborn Errors of Immunity	80
CME exam: Take a Leap of Faith: Implement Routine Genetic Testing in Your Office	80
Hypereosinophilia following aspirin desensitization for aspirin-exacerbated respiratory disease	79
Scratching the Itch: Managing Recurrent Pruritic Skin Conditions	74
CME Exam: Long-Term Respiratory Consequences of Early-Life Respiratory Viral Infections: A Pragmatic Approach to Fundamental Questions	71
Original Article Highlights From This Issue	70
COVID-19 Treatments: Then and Now	69
Original Article Highlights From This Issue	66
Hormonal Contraceptives Are Associated With an Increase in Incidence of Asthma in Women	66
Effects of Sex and Gender in Immediate β-Lactam Antibiotic Allergy: A Systematic Review and Meta-Analysis	64
Keeping Our Eyes on the Prize: Personalized and Precision Medicine With Biologics for Chronic Rhinosinusitis With Nasal Polyps	64
Immune Dysregulation in Human ITCH Deficiency Successfully Treated with Hematopoietic Cell Transplantation	63
Skin Antiseptics for Atopic Dermatitis: Dissecting Facts From Fiction	61

Ask Not What AI Can Do to Us, but What We Can Do with AI	61
Anaphylactic reaction to checkpoint inhibitors with confirmed hypersensitivity to polysorbate 80	59
Two-step nonsteroidal anti-inflammatory drug challenges during pregnancy: A case series	59
Reducing Health Disparities in Asthma: How Can Progress Be Made	57
Application of passive monitoring of nighttime respiratory symptoms in chronic asthma management	57
Resolution of hypereosinophilic syndrome following resection of a schwannoma	56
Giant Papillary Conjunctivitis Caused by a Fibroepithelial Polyp of the Lower Eyelid	55
Cumulative Dose Effects of H1 Antihistamine Use on the Risk of Dementia in Patients With Allergic Rhinitis	55
Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders	55
Losartan Treatment Reduces Esophageal Eosinophilic Inflammation in a Subset of Eosinophilic Esophagitis	54
Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases	54
Artificial Intelligence and Machine Learning for Inborn Errors of Immunity: Current State and Future Promise	54
Mepolizumab-responsive Kimura disease	54
Is Once Versus Twice Daily Dosing Better for Adherence in Asthma and Chronic Obstructive Pulmonary Disease?	53
Adherence Challenges and Strategies in Specific Groups With Asthma: Adolescents, Pregnancy, and Older Adults	53
Impact of Ongoing Treatment With Inhaled Corticosteroids During Specific Inhalation Challenges for Diagnosing Occupational Asthma	52
Once- or Twice-Daily Inhaler Therapy for Optimal Adherence: “No-Brainer” or Shared Decision?	51
Trends of Peanut-Induced Anaphylaxis Rates Before and After the 2017 Early Peanut Introduction Guidelines in Montreal, Canada	51
Chronic norovirus infection in immunodeficiency: A UK national case series	50
Respiratory Diseases Associated With Organic Dust Exposure	50
Could Corticosteroid/Antihistamine Combination Nasal Sprays Be Used as Anti-Inflammatory Reliever Therapy for Allergic Rhinitis?	50
Table of Contents	50
The Role of Patient Satisfaction Scores in Clinical Care and Physician Wellness	49
Another Therapy for Chronic Rhinosinusitis With Nasal Polyps	48
Respiratory Infections in Patients with Primary Immunodeficiency	48
Information for Readers	48
Persistent nivolumab-induced urticaria with vibratory and delayed-pressure angioedema	48
Allergic Rash Mimickers	47
Macular Amyloidosis in an Atopic Patient After Aeroallergen Immunotherapy	47
Measuring Cough Severity: Time to Replace VAS With Patient Global Impression Scale?	47
Managing CPAP Rhinitis	47
Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2)	46
Tocilizumab treatment in patients with Schnitzler syndrome: An open-label study	46
Generational Consequences From Historical Redlining: Longitudinal Impacts on Air Pollution and Asthma Health Outcomes	46
How to Measure Disease Activity, Impact, and Control in Patients with Recurrent Wheals, Angioedema, or Both	46
Quality and Safety: Learning from the Past and (Re)Imagining the Future	45
Carboplatin risk stratification after a hypersensitivity reaction: Progress in our understanding of skin testing	45
Pharmaceutical industry-sponsored meals and prescriptions of biologics for asthma	44
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Series of 49 French Pediatric Cases	44
Disparities in Genetic Testing for Inborn Errors of Immunity	43
Evolving Food Allergy Clinical Trials to Become More Patient-Centered	43
Risk Factors of Hypersensitivity Reactions to Carboplatin: A Systematic Review and Meta-Analysis	42
Triggers for Home Epinephrine-Treated Reactions During Oral Immunotherapy for Food Allergy	42
Table of Contents	42
Effects of Pregnancy-Onset Asthma on Perinatal Outcomes: A Retrospective Cohort Study	41
A Media Advocacy Toolkit for the Allergist-Immunologist	40
Prevention of IgE-Mediated Food Allergy: Emerging Strategies Through Maternal and Neonatal Interventions	39
Feeding difficulties in children with food protein–induced enterocolitis syndrome	39
The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia	39
Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America	39

Weight Loss Interventions for Adults With Obesity-Related Asthma	39
Identification of motivators and barriers impacting successful food introduction or reintroduction after negative oral food challenges	39
Assessment of Real-World Escalation to Biologics in US Patients With Asthma	39
Assessing Pediatric Cephalosporin Allergic Reactions Through Direct Graded Oral Challenges	39
Asthma Management in Children	38
Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines	38
FEF25-75% Is a More Sensitive Measure Reflecting Airway Dysfunction in Patients with Asthma: A Comparison Study Using FEF25-75% and FEV1%	38
Spirometric Changes in Bronchodilation Tests as Predictors of Asthma Diagnosis and Treatment Response in Patients with FEV1 ≥ 80% Predicted	38
Understanding Health Equity in Patient-Reported Outcomes	38
Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis	38
Lung Effects of Household Air Pollution	38
Development of Food Allergy Data Dictionary: Toward a Food Allergy Data Commons	38
Artificial Intelligence Chatbots in Allergy and Immunology Practice: Where Have We Been and Where Are We Going?	37
Clinical and diagnostic features of 33 patients with aquagenic urticaria	37
Cost Control Versus Optimal Patient Care in Hereditary Angioedema	37
Continuing Medical Education Calendar	37
Blue Wheals and Blue Angioedema Induced by Blue Dyes: A Systematic Review	36
Table of Contents	36
Continuing Medical Education Calendar	36
The Heterogeneity of Stock Epinephrine Legislation in the United States	36
CME exam: Triggers of Exacerbation in Chronic Urticaria and Recurrent Angioedema—Prevalence and Relevance	36
Preparing the Allergist/Immunologist for the Next Pandemic	36
Sesame-allergic patients can tolerate intact sesame seeds food challenge	36
Prevention of Drug Hypersensitivity Reactions: Prescreening and Premedication	36
Telemedicine utilization and incorporation of asynchronous testing in a pediatric allergy clinic during the COVID-19 pandemic	36
Practice Notes from the AAAI	36
Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era	36
CME exam: The Microbiome as a Gateway to Prevention of Allergic Disease Development	36
Angioedema due to Acquired C1-Inhibitor Deficiency Associated With Monoclonal Gammopathies of Undetermined Significance Characteristics of a French National Cohort	36
Domiciliary assessment of the type 2 inflammatory FeNO type	35
Continuing Medical Education Calendar	35
More Work to Do: Differential Responses to Asthma Therapies in Black Patients, Although Not Associated with Percentage of African Ancestry	35
Allergen Immunotherapy: A Long Way Gone and a Long Way to Go	34
September 2023 Practice Notes	34
Increasing diversity in peanut oral immunotherapy research and accessibility	34
The Th17/IL-17 Axis and Host Defense Against Fungal Infections	34
Reply to “Proposal for a new classification of vibratory urticaria/angioedema”	34
Preimplantation genetic testing for hereditary angioedema as a potential dominant cost-effective intervention	33
Clinical Characteristics of Irritant-Induced Occupational Asthma	33
Hazelnut Oral Immunotherapy Desensitizes Hazelnut But Not Other Tree Nut Allergies (Nut CRACKER Study)	32
Social Determinants and Quality of Life in Food Allergy Management and Treatment	32
Efficacy of lanadelumab in angioedema due to acquired C1 inhibitor deficiency	32
Table of Contents	32
Barriers and Enablers of Dietary Reintroduction Following Negative Oral Food Challenge: A Scoping Review	32
Burden of Allergic Disease in Racial and Ethnic Structurally Oppressed Communities Within Canada and the United States: A Scoping Review	32
Severity Trend of Recurrence in Pediatric Food Protein-Induced Enterocolitis Syndrome	32
Factors Associated With Asthma Biologic Prescribing and Primary Adherence Among Adults in a Large Health System	32
Teleallergy: Where Have We Been and Where Are We Going?	32
Immediate adverse reactions to horse antithymocyte globulin: A 10-year single-center experience	31
Use of Antibiotics in Infancy and Asthma in Childhood: Confounded or Causal Relationship? A Critical Review of the Literature	31
Hypersensitivity to galcanezumab with tolerance to erenumab and fremanezumab	31
Sensitization is persistent in most patients with anaphylaxis to a cephalosporin at 10 years	31
Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma	31
Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes From an International Survey	31
Telehealth and Allergy Services in Rural and Regional Locations That Lack Specialty Services	30
Patient Perceptions of Penicillin Allergy Testing in a Public Health System	30
Safety of direct oral challenge to amoxicillin in pregnant patients at a Canadian tertiary hospital	30
The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma	30
Frequent Allergic Sensitization to Farmed Edible Insects in Exposed Employees	30
Food Insecurity in the Food Allergic Population: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee	30
Complications of switching from anti–IL-5 or anti–IL-5R to dupilumab in corticosteroid-dependent severe asthma	30
Multiple chemical sensitivity/idiopathic environmental intolerance: A disability-rights, patient-led perspective	29
Erratum	29
Comorbid Scenarios in Contact Dermatitis: Atopic Dermatitis, Irritant Dermatitis, and Extremes of Age	29
Upadacitinib-induced remission of allergic asthma: A case report	29
Systemic Therapies for Atopic Dermatitis	29
Clinical Assessment of Chronic Rhinosinusitis	29
Editorial Board	29
December 2023 Practice Notes	29
The added value of reporting likelihood ratios to laboratory test results in allergy and clinical immunology	29
Correction	29
Correction	29
Does atopic dermatitis confer a clinically meaningful risk of cardiovascular disease?	28
Reply to “Do rural health disparities affect prevalence data in pediatric eosinophilic esophagitis?”	28
Potential Efficacy of High-Dose Inhaled Salbutamol for the Treatment of Abdominal Pain During Oral Food Challenge	28
Trends in Emergency Department Visits and Hospitalizations for Acute Allergic Reactions and Anaphylaxis Among US Older Adults: 2006-2014	28
Take a Leap of Faith: Implement Routine Genetic Testing in Your Office	28
Infrared-induced hives	28
The Challenges of Managing Multiple Food Allergies and Consequent Food Aversions	27
Omalizumab treatment reduces asthma exacerbations regardless of airway bronchodilator reversibility	27

Patient Global Impression of Severity Scale in Chronic Cough: Validation and Formulation of Symptom Severity Categories	27
Outcomes among racial and ethnic minority groups with X-linked agammaglobulinemia from the USIDNET registry	27
The Prevalence of IgE-Mediated Food Allergy and Other Allergic Diseases in the First 10 Years: The Population-Based, Longitudinal HealthNuts Study	27
Asian American Patients With Allergic Diseases: Considerations for Research and Clinical Care	27
Remission of indolent systemic mastocytosis in the absence of targeted therapy	27
Screening Newborns for Low T Cell Receptor Excision Circles (TRECs) Fails to Detect Immunodeficiency, Centromeric Instability, and Facial Anomalies Syndrome	27
Effectiveness of Carboplatin-Prescreening Intradermal Skin Tests to Reduce Unanticipated Immediate Hypersensitivity Reactions: A Comparative Study	27
The Use of Flexible Rhinolaryngoscopy for Allergy-Immunology Practice	27
Omalizumab in Chronic Spontaneous Urticaria (CSU): Real-Life Experience in Dose/Interval Adjustments and Treatment Discontinuation	27
Exploring barriers to commercial peanut oral immunotherapy treatment during COVID-19	27
Improving Detection of Alpha-1 Antitrypsin Deficiency: Role of the Allergist	27
Risk Factors and Age-Related Patterns of Asthma-Like Symptoms in Early Childhood	26
Gender and Geographically-Based Disparities Among Editors and Editorial Board Members in Highly-Cited Allergy Journals	26
Accelerating Food Allergy Research: Need for a Data Commons	26
Acculturation and asthma in Asian American adults	26
Systemic Inflammation in Asthma: What Are the Risks and Impacts Outside the Airway?	26
The Environmental Microbiome, Allergic Disease, and Asthma	26
Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts	26
Treatment expectations in food-allergic patients referred for oral immunotherapy	26
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical presentation and outcomes in people of color	25
Elimination Diet or Swallowed Topical Steroid Treatment of Pediatric Eosinophilic Esophagitis: Five-Year Outcomes	25
Artificial Intelligence/Machine Learning in Respiratory Medicine and Potential Role in Asthma and COPD Diagnosis	25
Exercising with Asthma: A Slow Burn or a Quick HIIT?	25
Comparison of Standard, Cluster, and Rush Allergy Immunotherapy Buildup Protocols	25
Original Article Highlights From This Issue	25
Perceived high risk of COVID-19 vaccination: The revealing power of placebo	25
Real-world utilization of Arachis hypogaea for peanut allergy: Patient and provider perspective	25
Beyond Avoidance: Advanced Therapies for Contact Dermatitis	25
Challenges and Opportunities in Asthma Prevention and Treatment	25
Novel Connections of Common Childhood Illnesses Based on More Than 5 Million Diary Registrations From Birth Until Age 3 Years	25
Identifying Subtypes of Paucigranulocytic Asthma: Now There Are 3	24
Smoke and the Lungs	24
Trust but Verify	24
Pretreatment with ibrutinib facilitates rapid drug desensitization in a difficult case of brentuximab vedotin–induced anaphylaxis	24
A Community-Based Participatory Research Approach to Understanding Childhood Asthma in the Navajo Nation	24
The impact of inhaled corticosteroid on SARS-CoV2 infection	24
Drug Allergy Management on the Move	24
Contact Dermatitis of a Surgical Wound	24
Patient-Centered Immunotherapy: Empowering Patients With Dosing Schedule Education and Self-Tracking Modality	24
Folliculocentric Mycosis Fungoides Masquerading as Angioedema and Allergic Contact Dermatitis	24
Polycystic ovary syndrome and the risk of asthma in reproductive-age women: Insights from 2 real-world large cohorts	24
Update on Influenza Vaccines: Needs and Progress	24
Asthma and Three Colinear Comorbidities: Obesity, OSA, and GERD	24
Should We Pretreat Before We Go Nuts? Antihistamines Modestly Reduce the Side Effects of Peanut Oral Immunotherapy	24
About the Cover: A New “Image” for In Practice	24
Recent Advances in the Treatment of Eosinophilic Esophagitis	24
Analyzing Racial Disparities in Pediatric Atopic Comorbidity Emergency Department Visitation Using Electronic Health Records	23
Drug Reaction With Eosinophilia and Systemic Symptoms: A Systematic Review	23
The Magnification of Health Disparities During the COVID-19 Pandemic	23
Genetic counseling in pediatric inborn errors of immunity: Perspective piece on current practice and considerations	23
Inborn Errors of Immunity: A Role for Functional Testing and Flow Cytometry in Aiding Clinical Diagnosis	23
Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease	23
Relationships Between Chronic Cough and Asthma Control and Quality of Life in Patients With Severe Asthma: A 6-Month Longitudinal Analysis	23
Cost-Effectiveness of Tiotropium in Elderly Patients with Severe Asthma Using Real-World Data	23
Association between social needs and asthma control among children evaluated at a single-center high-risk asthma clinic	23
Clinical Remission in Patients With Biologic-Naïve Asthma: A Multicenter Study in Japan	23
Interaction Between Baseline Participant Factors and Treatment Effects Following Peanut Oral Immunotherapy	23
Subcutaneous Emphysema Presenting as Bilateral Periorbital Angioedema	23
Outpatient epinephrine administration reduces ICU admission rates in anaphylactic reactions: A propensity score–matched cohort	23
Altered Symptom Perception in Children With Asthma Is Associated With Poor Childhood Opportunity and Adverse Outcomes	23
Real-World Effectiveness of Biologic Therapy in Allergic Bronchopulmonary Aspergillosis	23
Environmental Injustice Is Associated With Poorer Asthma Outcomes in School-Age Children With Asthma in Metropolitan Atlanta, Georgia	23
Milk or egg allergy diagnosis increases the risk of eosinophilic esophagitis diagnosis	23
Reply to “The use of basophil activation tests (BATs) in the diagnosis of penicillin allergy”	23
Allergic bronchopulmonary aspergillosis in identical twins: Effectiveness of dupilumab	23
Corrections	22
A single-center experience of treating 19 patients with chronic cold urticaria	22
The Art of Dosing for Subcutaneous Immunotherapy in North America	22
Pulmonary Infiltrates With Hypereosinophilia	22
Fatigue in Severe Uncontrolled Asthma	22
Why Was There Ever a Warning Not to Use Cephalosporins in the Setting of a Penicillin “Allergy”?	22
CME exam: Methods for Cross-Cultural Communication in Clinic Encounters	22
Original Article Highlights From This Issue	22
Exfoliative Dermatitis During Antituberculosis Treatment	22
COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach	22
Biologics and Personalized Medicine in Severe Asthma: One Step at a Time	22
Allergic Mucin in Allergic Fungal Rhinosinusitis	22
Partnering with Patients and Communities to Improve Prehospital Anaphylaxis Care	22
Eosinophilic Esophagitis Patients Are Not at Increased Risk of Severe COVID-19: A Report From a Global Registry	22
Information for Readers	22
The Art of Immunotherapy	22
Association Between Blood Eosinophils and Neutrophils With Clinical Features in Adult-Onset Asthma	21
CME exam: An Adolescent with Respiratory Distress	21
Novel Questionnaires for Assessing Signs and Symptoms of Eosinophilic Esophagitis in Children	21
Delayed Skin Testing for Systemic Medications: Helpful or Not?	21
Comorbid Inducible Urticaria Is Linked to Non-Autoimmune Chronic Spontaneous Urticaria: CURE Insights	21
Experience transitioning post–food allergy clinical trial participants to daily ingestion of retail food equivalents	21
Racial and Ethnic Disparities in the Research and Care of Hereditary Angioedema Patients in the United States	21
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus	21
CME Exam: Difficult-to-Control Asthma Management in Adults	21
Increased Risk of Atrial Fibrillation in Patients with Atopic Triad: A Nationwide Population-Based Study	21
Reply to “Challenging dated conceptions to advocate for evidence-informed care in multiple chemical sensitivity”	21
Use of ruxolitinib to control graft-versus-host–like disease in Omenn syndrome and successfully bridging to HSCT	21
Budesonide/Formoterol or Budesonide/Albuterol as Anti-Inflammatory Reliever Therapy for Asthma	21
Positive Basophil Tests Are Linked to High Disease Activity and Other Features of Autoimmune Chronic Spontaneous Urticaria: A Systematic Review	21